Delivery Order SPE2DB22D2206-SPE2DB24FGM67
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FOTIVDA 0.89 MG CAPSULE 21S. The contract has a firm fixed price of $16,135.20 and a period of performance extending to July 3, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FOTIVDA 1.34 MG CAPSULE 21S, a pharmaceutical product, with a ceiling value of $15,953.54 and a completion date of July 2, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp for FOTIVDA 1.34 mg capsule supply (21-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract is not set-aside and represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FOTIVDA 1.34 MG CAPSULE 21S. The contract has a firm fixed price of $31,907.08 and a completion date of June 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $31,192.36, is for the supply of the pharmaceutical product FOTIVDA 0.89 MG CAPSULE 21S. As a prime contractor, Amerisourcebergen Drug Corp has provided a range of pharmaceutical and medical products to support DLA Troop Support Medical programs and facilities. The contract has a completion date of January...
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for FOTIVDA 1.34 mg capsules (21-count). This contract, which is non-set-aside and competitively awarded, is structured as a firm fixed price delivery order with a completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp for Fotivda 1.34 mg capsules (21-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order under an undisclosed contract vehicle to AmerisourceBergen Drug Corporation for the supply of 21 capsules of the pharmaceutical FOTIVDA at 0.89 mg each. Valued at $15,596.18 with a firm fixed price, the order is to be performed in Conshohocken, Pennsylvania between August 22nd and September 13th, 2023. As a major provider of medical supplies and pharmaceuticals to the U.S. military, this order for cancer treatment medication supports the...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $46,261.74 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to supply 21 packages of the 1.34 mg Fotivda capsule. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding in late September 2023. The Defense Logistics Agency Troop Support Medical utilizes contracts such as this to efficiently procure...
- The Defense Logistics Agency awarded a delivery order valued at $15,596.18 to Amerisourcebergen Drug Corporation for the supply of 21 capsules of Fotivda, an oncology drug used to treat renal cell carcinoma. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania within the period of performance of June 27, 2023 through July 19, 2023. The firm fixed price contract was awarded utilizing Amerisourcebergen's position on an...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGM67Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, through its Corporate Office division, to provide FOTIVDA 0.89 MG CAPSULE 21S, a specialty pharmaceutical product, with a ceiling value of $32,652.72 and a performance period through April 25, 2024. The award is a firm fixed price contract and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceuticals and medical supplies to the Department of Defense, primarily through delivery orders and indefinite delivery contracts with DLA Troop Support Medical. This specific award is a delivery order issued against an indefinite delivery contract valued at up to $999,999,999.00 and with a performance period through December 31, 2025, which enables AmerisourceBergen to deliver a comprehensive range of medications and healthcare materials to military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.7k | 4/4/24 |